Measured by its ability to inhibit TNF-beta -mediated cytotoxicity using L‑929 mouse fibroblast cells. The ED50 for this effect is 2.5-10 µg/mL in the presence of 50 pg/mL of Recombinant Human TNF‑ beta /TNFSF1.
Receptor for BTLA. Receptor for TNFSF14/LIGHT and homotrimeric TNFSF1/lymphotoxin-alpha. Involved in lymphocyte activation. Plays an important role in HSV pathogenesis because it enhanced the entry of several wild-type HSV strains of both serotypes into CHO cells, and mediated HSV entry into activated human T-cells.
Post-translational: N-glycosylated.
生物活性
Measured by its ability to inhibit TNF-beta -mediated cytotoxicity using L‑929 mouse fibroblast cells. The ED50 for this effect is 2.5-10 µg/mL in the presence of 50 pg/mL of Recombinant Human TNF‑ beta /TNFSF1.
Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH7.4.
复溶
Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20~-80℃ 下可保存 1 年以上。收货后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human HVEM/TNFRSF14 Protein (rp152534) - SDS-PAGE 3 μg/lane of Recombinant Human HVEM/TNFRSF14 Protein was resolved with SDS-PAGE under reducing (R) conditions and visualized by Coomassie® Blue staining, showing the band at 25 - 35 kDa.
ZJ24F1215902
危险品化学品经营许可证（带存储）